{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:21:36Z","timestamp":1790749296348,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","award":["GGP17102"],"award-info":[{"award-number":["GGP17102"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.phrs.2023.106823","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T11:31:43Z","timestamp":1687001503000},"page":"106823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington\u2019s disease"],"prefix":"10.1016","volume":"194","author":[{"given":"Giulia","family":"Birolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Valenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ottonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Talpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Minoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Bombaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Caccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Canevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Trucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Passoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Favagrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Paltrinieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Bagnati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Thomas","family":"Duskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Caraffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Vandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Taroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Salmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Scanziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Biella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ruozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106823_bib1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.15252\/embr.201439225","article-title":"Cholesterol in brain disease: sometimes determinant and frequently implicated","volume":"15","author":"Mart\u00edn","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2023.106823_bib2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2023.106823_bib3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2023.106823_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","author":"R\u00fcb","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2023.106823_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2023.106823_bib6","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation","volume":"16","author":"Valenza","year":"2007","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.phrs.2023.106823_bib7","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awz174","article-title":"CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease","volume":"142","author":"Kacher","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2023.106823_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","article-title":"Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington\u2019s disease: A cross-validation study in Q175 knock-in mice","volume":"98","author":"Shankaran","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2023.106823_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1471-4159.1995.64020895.x","article-title":"Cholesterol for synthesis of myelin is made locally, not imported into brain","volume":"64","author":"Jurevics","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2023.106823_bib10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106823_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2022.01.002","article-title":"Brain cell type-specific cholesterol metabolism and implications for learning and memory","volume":"45","author":"Li","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2023.106823_bib12","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2023.106823_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington\u2019s disease","volume":"494","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2023.106823_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","article-title":"Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression","volume":"55","author":"Leoni","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2023.106823_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2023.106823_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.15252\/emmm.201505413","article-title":"Cholesterol\u2010loaded nanoparticles ameliorate synaptic and cognitive function in H untington\u2019s disease mice","volume":"7","author":"Valenza","year":"2015","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.phrs.2023.106823_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012519","article-title":"Striatal infusion of cholesterol promotes dose\u2010dependent behavioral benefits and exerts disease\u2010modifying effects in Huntington\u2019s disease mice","volume":"12","author":"Birolini","year":"2020","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.phrs.2023.106823_bib18","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awab186","article-title":"SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes","volume":"144","author":"Birolini","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2023.106823_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.03.061","article-title":"Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain","volume":"543","author":"Belletti","year":"2018","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.phrs.2023.106823_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","article-title":"Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington\u2019s disease","volume":"330","author":"Birolini","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2023.106823_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s Disease: ZQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106823_bib22","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","article-title":"An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes","volume":"25","author":"Southwell","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.phrs.2023.106823_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acschemneuro.9b00581","article-title":"Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington\u2019s Disease","volume":"11","author":"Passoni","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2023.106823_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2014.01.004","article-title":"Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport","volume":"177","author":"Tosi","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2023.106823_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington\u2019s disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurbiol"},{"key":"10.1016\/j.phrs.2023.106823_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: Insights from Huntington\u2019s disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2023.106823_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington\u2019s Disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106823_bib28","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1152\/jn.01056.2014","article-title":"Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease","volume":"113","author":"Indersmitten","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.phrs.2023.106823_bib29","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1172\/JCI120616","article-title":"Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington\u2019s disease","volume":"129","author":"Vezzoli","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2023.106823_bib30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/cdd.2014.162","article-title":"Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease","volume":"22","author":"Valenza","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2023.106823_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2023.106823_bib32","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106823_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2023.106823_bib34","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41591-019-0478-3","article-title":"Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington\u2019s disease","volume":"25","author":"Zeitler","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2023.106823_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.696778","article-title":"Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications","volume":"13","author":"Pikuleva","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.phrs.2023.106823_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161769","article-title":"Benefits of global mutant huntingtin lowering diminish over time in a Huntington\u2019s disease mouse model","volume":"7","author":"Marchionini","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2023.106823_bib37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/mds.23606","article-title":"Coordination of fingertip forces during precision grip in premanifest Huntington\u2019s disease","volume":"26","author":"Rao","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2023.106823_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pneurobio.2013.08.003","article-title":"A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases","volume":"110","author":"Paulsen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2023.106823_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000481172","article-title":"Huntington\u2019s Disease: Premotor Phase","volume":"17","author":"Ramos","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.phrs.2023.106823_bib40","doi-asserted-by":"crossref","first-page":"14664","DOI":"10.1073\/pnas.0907299106","article-title":"Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors","volume":"106","author":"Darvas","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2023.106823_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/2398212820972599","article-title":"Spontaneous object-location memory based on environmental geometry is impaired by both hippocampal and dorsolateral striatal lesions","volume":"4","author":"Poulter","year":"2020","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.phrs.2023.106823_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2017.10.006","article-title":"Amygdala inhibitory circuits regulate associative fear conditioning","volume":"83","author":"Krabbe","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2023.106823_bib43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fnhum.2018.00250","article-title":"The complex nature of hippocampal-striatal interactions in spatial navigation","volume":"12","author":"Goodroe","year":"2018","journal-title":"Front Hum. Neurosci."},{"key":"10.1016\/j.phrs.2023.106823_bib44","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1074\/jbc.M601019200","article-title":"24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux","volume":"281","author":"Abildayeva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106823_bib45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1177\/0192623309347911","article-title":"Subcutaneous and intraperitoneal lipogranulomas following subcutaneous injection of olive oil in sprague-dawley rats","volume":"37","author":"Ramot","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.phrs.2023.106823_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/d41573-023-00083-z","article-title":"NfL makes regulatory debut as neurodegenerative disease biomarker","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2023.106823_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/1541-7786.MCR-20-0650","article-title":"Intraperitoneal oil application causes local inflammation with depletion of resident peritoneal macrophages","volume":"19","author":"Alsina-Sanchis","year":"2021","journal-title":"Mol. Cancer Res."}],"updated-by":[{"DOI":"10.1016\/j.phrs.2025.108001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:18:04Z","timestamp":1766071084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"alternative-id":["S1043661823001792"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106823","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.26.505426","asserted-by":"object"}]},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106823"}}